Naloxone hydrochloride 40 MG/ML Nasal Spray — RxCUI 1725059
RxNorm drug concept · Semantic clinical drug
RxCUI 1725059
Semantic clinical drug · SCD
● Current RxNorm concept 26 FDA products
31 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1725059
Official nameNaloxone hydrochloride 40 MG/ML Nasal Spray
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asnaloxone HCl 4 MG per 0.1 ML Nasal Spray; naloxone HCl 4 MG in 0.1 ML Nasal Spray
FDA products mapped26
Package NDCs mapped31
Reported Medicaid activity (SDUD)909,630 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Naloxone Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Naloxone works by knocking opioids off their receptors in the brain — the spots opioids attach to in order to cause their effects. When those receptors are blocked by naloxone, bre...
- What exactly does naloxone injection do in an overdose?
- Call 911 immediately — that's not optional. Naloxone wears off faster than most opioids, so even if the person wakes up and seems okay, they can slip back into overdose once the na...
- What do I do after I give someone a dose of naloxone injection?
🕸️ Concept Web — How Naloxone hydrochloride 40 MG/ML Nasal Spray Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Naloxone hydrochloride 40 MG/ML Nasal Spray
RxCUI 1725059 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Naloxone
7242IN -
Naloxone hydrochloride
203192PIN
-
Naloxone
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Narcan
197117BN
-
Narcan
-
Dose forms 13
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Naloxone Nasal Spray
1725058SCDF -
Naloxone hydrochloride Nasal Spray
2648679SCDFP -
Naloxone Inhalant Product
1725056SCDG -
Naloxone Nasal Product
1725057SCDG -
Naloxone hydrochloride Inhalant Product
2660326SCDGP -
Naloxone hydrochloride Nasal Product
2663067SCDGP -
Naloxone Nasal Spray [Narcan]
1725061SBDF -
Naloxone hydrochloride Nasal Spray [Narcan]
2655061SBDFP - +5 more in this family
-
Naloxone Nasal Spray
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Naloxone hydrochloride 40 MG/ML
1725055SCDC -
Naloxone hydrochloride 40 MG/ML Nasal Spray [Narcan]
1725064SBD -
Naloxone hydrochloride 40 MG/ML [Narcan]
1725060SBDC
-
Naloxone hydrochloride 40 MG/ML
Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Naloxone hydrochloride 40 MG/ML
SCDC · 1725055 -
Naloxone Nasal Spray
SCDF · 1725058 -
Naloxone hydrochloride Nasal Spray
SCDFP · 2648679 -
Naloxone Inhalant Product
SCDG · 1725056 -
Naloxone Nasal Product
SCDG · 1725057 -
Naloxone hydrochloride Inhalant Product
SCDGP · 2660326 -
Naloxone hydrochloride Nasal Product
SCDGP · 2663067
Brand-Name Concepts
-
Naloxone hydrochloride 40 MG/ML Nasal Spray [Narcan]
SBD · 1725064 -
Naloxone hydrochloride 40 MG/ML [Narcan]
SBDC · 1725060 -
Naloxone Nasal Spray [Narcan]
SBDF · 1725061 -
Naloxone hydrochloride Nasal Spray [Narcan]
SBDFP · 2655061 -
Narcan Inhalant Product
SBDG · 1725062 -
Narcan Nasal Product
SBDG · 1725063 -
Narcan
BN · 197117
📦 FDA Products & Package NDCs
26 products · 31 package NDCs
31 package NDCs map to RxCUI 1725059 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00363-2140-02 | 2 VIAL in 1 CARTON (0363-2140-02) / .1 mL in 1 VIAL (0363-2... | Naloxone Hydrochloride | Walgreen Co. | 2024-04-24 |
| 00480-3478-68 | 2 BLISTER PACK in 1 CARTON (0480-3478-68) / 1 VIAL, SINGLE-... | Naloxone Hydrochloride | Teva Pharmaceuticals, Inc. | 2024-09-23 |
| 00591-3871-99 | 2 BLISTER PACK in 1 CARTON (0591-3871-99) / 1 VIAL, SINGLE-... | Naloxone Hydrochloride | Actavis Pharma, Inc. | 2025-01-17 |
| 42291-0493-02 | 2 VIAL, SINGLE-DOSE in 1 CARTON (42291-493-02) / .1 mL in 1... | Naloxone Hydrochloride | AvKARE | 2024-05-01 |
| 45802-0578-24 | 24 VIAL, SINGLE-DOSE in 1 CARTON (45802-578-24) / .1 mL in... | NALOXONE HYDROCHLORIDE | Padagis Israel Pharmaceuticals Ltd | 2025-08-01 |
| 45802-0578-84 | 2 VIAL, SINGLE-DOSE in 1 CARTON (45802-578-84) / .1 mL in 1... | NALOXONE HYDROCHLORIDE | Padagis Israel Pharmaceuticals Ltd | 2023-07-30 |
| 46122-0812-71 | 2 VIAL, SINGLE-DOSE in 1 CARTON (46122-812-71) / .1 mL in 1... | NALOXONE HYDROCHLORIDE | AMERISOURCE BERGEN | 2025-03-12 |
| 50090-2422-00 | 2 VIAL, SINGLE-DOSE in 1 PACKAGE (50090-2422-0) / .1 mL in... | NARCAN | A-S Medication Solutions | 2017-01-24 |
| 50090-5908-00 | 2 VIAL, SINGLE-DOSE in 1 CARTON (50090-5908-0) / .1 mL in 1... | Naloxone Hydrochloride | A-S Medication Solutions | 2022-01-19 |
| 50090-6710-00 | 2 VIAL, SINGLE-DOSE in 1 CARTON (50090-6710-0) / .1 mL in 1... | NALOXONE HYDROCHLORIDE | A-S Medication Solutions | 2023-09-28 |
| 50090-6963-00 | 2 VIAL, SINGLE-DOSE in 1 CARTON (50090-6963-0) / .1 mL in 1... | NALOXONE HYDROCHLORIDE | A-S Medication Solutions | 2023-12-20 |
| 51316-0210-02 | 2 VIAL in 1 CARTON (51316-210-02) / .1 mL in 1 VIAL (51316-... | Naloxone Hydrochloride | CVS Pharmacy, Inc | 2024-04-24 |
| 51662-1240-01 | .1 mL in 1 VIAL, SINGLE-DOSE (51662-1240-1) | NARCAN NALOXONE HCI | HF Acquisition Co LLC, DBA HealthFirst | 2018-10-15 |
| 51662-1240-02 | 2 VIAL, SINGLE-DOSE in 1 PACKAGE (51662-1240-2) / .1 mL in... | NARCAN NALOXONE HCI | HF Acquisition Co LLC, DBA HealthFirst | 2018-10-15 |
| 51662-1620-01 | .1 mL in 1 VIAL, SINGLE-DOSE (51662-1620-1) | NALOXONE HCl | HF Acquisition Co LLC, DBA HealthFirst | 2023-04-10 |
| 51662-1620-02 | 2 VIAL, SINGLE-DOSE in 1 CARTON (51662-1620-2) / .1 mL in 1... | NALOXONE HCl | HF Acquisition Co LLC, DBA HealthFirst | 2023-04-10 |
| 51662-1659-02 | 2 VIAL, SINGLE-DOSE in 1 CARTON (51662-1659-2) / .1 mL in 1... | NALOXONE HYDROCHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | 2023-07-30 |
| 60219-2104-07 | 2 VIAL in 1 CARTON (60219-2104-7) / .1 mL in 1 VIAL (60219-... | Naloxone Hydrochloride | Amneal Pharmaceuticals NY LLC | 2024-04-24 |
| 68001-0645-45 | 2 VIAL, SINGLE-DOSE in 1 CARTON (68001-645-45) / .1 mL in 1... | NALOXONE HYDROCHLORIDE | BluePoint Laboratories | 2025-05-01 |
| 69238-2104-07 | 2 VIAL, SINGLE-DOSE in 1 CARTON (69238-2104-7) / .1 mL in 1... | Naloxone Hydrochloride | Amneal Pharmaceuticals NY LLC | 2024-04-24 |
| 69547-0627-02 | 2 VIAL, SINGLE-DOSE in 1 CARTON (69547-627-02) / .1 mL in 1... | NARCAN | Emergent Devices Inc. | 2023-08-28 |
| 69547-0627-05 | 1 CASE in 1 CARTON (69547-627-05) / 2 VIAL, SINGLE-DOSE in... | NARCAN | Emergent Devices Inc. | 2026-03-15 |
| 69547-0627-06 | 6 VIAL, SINGLE-DOSE in 1 CARTON (69547-627-06) / .1 mL in 1... | NARCAN | Emergent Devices Inc. | 2026-03-15 |
| 69547-0627-24 | 24 VIAL, SINGLE-DOSE in 1 CARTON (69547-627-24) / .1 mL in... | NARCAN | Emergent Devices Inc. | 2026-03-15 |
| 70677-1283-01 | 2 VIAL, SINGLE-DOSE in 1 CARTON (70677-1283-1) / .1 mL in 1... | NALOXONE HYDROCHLORIDE | Strategic Sourcing Services LLC | 2025-04-01 |
| 71205-0528-02 | 2 VIAL, SINGLE-DOSE in 1 PACKAGE (71205-528-02) / .1 mL in... | Narcan | Proficient Rx LP | 2021-02-03 |
| 71205-0707-02 | 2 VIAL, SINGLE-DOSE in 1 CARTON (71205-707-02) / .1 mL in 1... | NALOXONE HYDROCHLORIDE | Proficient Rx LP | 2022-10-20 |
| 72162-2376-02 | 2 VIAL, SINGLE-DOSE in 1 CARTON (72162-2376-2) / .1 mL in 1... | NALOXONE HYDROCHLORIDE | Bryant Ranch Prepack | 2024-10-03 |
| 76420-0867-02 | 2 BLISTER PACK in 1 CARTON (76420-867-02) / 1 VIAL, SINGLE-... | Naloxone Hydrochloride | Asclemed USA, Inc. | 2024-10-29 |
| 80425-0409-01 | 2 VIAL, SINGLE-DOSE in 1 CARTON (80425-0409-1) / .1 mL in 1... | NALOXONE HYDROCHLORIDE | Advanced Rx of Tennessee, LLC | 2024-06-27 |
| 85766-0076-02 | 2 VIAL, SINGLE-DOSE in 1 CARTON (85766-076-02) / .1 mL in 1... | NARCAN | Sportpharm LLC | 2025-10-10 |
Observed labelers:
HF Acquisition Co LLC, DBA HealthFirst (5) ·
A-S Medication Solutions (4) ·
Emergent Devices Inc. (4) ·
Amneal Pharmaceuticals NY LLC (2) ·
Padagis Israel Pharmaceuticals Ltd (2) ·
Proficient Rx LP (2)
· +12 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.